Insomnia
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Subjects eligible for inclusion in this study must meet all of the following criteria: (1) Reside in an area with an altitude =2500 meters; (2) Be between 18 and 60 years old; (3) Possess basic reading and writing skills and be able to complete questionnaires independently; (4) Voluntarily participate in this study and sign the informed consent; (5) Meet the diagnostic criteria for insomnia; (6) Be right-handed.
Exclusion criteria
Exclusion criteria: Any subject meeting any of the following criteria will be excluded: (1) Subjects diagnosed with insomnia in plain areas; (2) Patients with severe physical diseases or mental disorders; (3) Patients with severe anxiety or depression (SDS =73 points, SAS =70 points); (4) Subjects who have regularly taken sedative-hypnotic or other sleep aids, or antidepressant and anti-anxiety medications within the past month; (5) Subjects currently participating in other clinical trials for interventions targeting insomnia; (6) Other subjects deemed unsuitable for participation in the clinical trial by the investigators for any reason.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Changes in Central Response Characteristics Before and After Treatment - Functional Near-Infrared Spectroscopy (fNIRS);Primary efficacy evaluation - Pittsburgh Sleep Quality Index (PSQI) score; | — |
Secondary
| Measure | Time frame |
|---|---|
| Secondary efficacy assessment - Insomnia Severity Index (ISI) score;Secondary efficacy evaluation - Self-Rating Anxiety Scale (SAS) score;Secondary efficacy evaluation - Self-Rating Depression Scale (SDS) score; | — |
Countries
China
Contacts
General Hospital of Western Theater Command of the People's Liberation Army